Pharmafile Logo

Delivering outcomes-led solutions with connected capabilities

- PMLiVE

Founded in 2007, Lucid Group has grown from a small UK-based medical education agency to a global healthcare consultancy and employs over 400 people with several offices in the UK and US.

We partner with the pharma and biotech industry to deliver pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.

Through a relentless pursuit to increase the impact of our work, we pioneered the use of health psychology within medical communications to influence behaviour change, the impact was game-changing and demonstrated a paradigm shift in disease management and health outcomes.

Today we are a multi-capability healthcare consultancy working across the lifecycle. We have experience and deep scientific knowledge in a multitude of different therapy areas, culminating in many hundreds of years of combined knowledge and understanding.

By connecting our best-in-class capabilities and applying them at the right time we can better understand and fix healthcare problems with outcomes-led solutions — delivering life-transforming value for everyone.

Our core capabilities

Creative & brand strategy

We put brands front of mind. No matter where a brand or portfolio of brands may be in their lifecycle, our team of strategists, scientists, data analysts and creatives are masters in collaboration and brand building. Working together, we help our clients unlock potential with hidden truths to tell a story and create an experience that touches the hearts and minds of the audience.

Medical strategy

Our deep understanding of the complex challenges and responsibilities of medical affairs today allows us to connect the perfect capabilities to create the perfect strategies for our clients. This is achieved via a robust and relevant scientific platform that realises the potential of assets, making sure the right medicines reach the right patients at the right time.

Healthcare communications

We combine our shared expertise to create scientific communication strategies and design aligned medical communication solutions. Our aim is to create scientific stories and experiences that are translated globally across affiliates and disseminated through the right channels to the right audiences to drive a meaningful difference in clinical practice and health outcomes.

Motion, digital & technology

Using the latest technology, we help our clients create joined-up experiences regardless of channel. Through audience-focused design, we can fuse digital and motion with our scientific and creative capabilities to provide compelling experiences that take the audience on a journey – empowering them to learn, understand and act.

Behaviour change

We pioneer the use of health psychology to influence behaviour change within medical education. We apply our approach, Advance Outcomes™, to make sustained and meaningful improvements in clinical practice that improves health outcomes.​

Metrics & data analytics

We measure the impact of our work; establishing, tracking and benchmarking performance, and continually optimising results. From market performance to prescription and bespoke data sets, we translate complex data into meaningful insights and actionable strategy. We use data analytics to better understand operational performance, so we can apply the right capabilities at the right time to allow our clients to optimise their execution and improve health outcomes for patients.

For further information on our capabilities, or access to advice on healthcare communication challenges please get in touch with Clare Reynolds.

clare.reynolds@wearelucidgroup.com

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.